UnitedHealth Non Current Liabilities Other from 2010 to 2025

UNH Stock  USD 516.04  0.32  0.06%   
UnitedHealth Group's Non Current Liabilities Other is increasing with slightly volatile movements from year to year. Non Current Liabilities Other is predicted to flatten to about 8.7 B. For the period between 2010 and 2025, UnitedHealth Group, Non Current Liabilities Other quarterly trend regression had mean deviation of  4,374,537,256 and range of 13.5 B. View All Fundamentals
 
Non Current Liabilities Other  
First Reported
2009-06-30
Previous Quarter
15.2 B
Current Value
15.9 B
Quarterly Volatility
4.9 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check UnitedHealth Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among UnitedHealth Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.3 B, Total Revenue of 420.3 B or Gross Profit of 93.9 B, as well as many indicators such as Price To Sales Ratio of 1.18, Dividend Yield of 0.0168 or PTB Ratio of 3.22. UnitedHealth financial statements analysis is a perfect complement when working with UnitedHealth Group Valuation or Volatility modules.
  
Check out the analysis of UnitedHealth Group Correlation against competitors.

Latest UnitedHealth Group's Non Current Liabilities Other Growth Pattern

Below is the plot of the Non Current Liabilities Other of UnitedHealth Group Incorporated over the last few years. It is UnitedHealth Group's Non Current Liabilities Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in UnitedHealth Group's overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Other10 Years Trend
Slightly volatile
   Non Current Liabilities Other   
       Timeline  

UnitedHealth Non Current Liabilities Other Regression Statistics

Arithmetic Mean8,179,588,672
Geometric Mean6,841,078,622
Coefficient Of Variation60.50
Mean Deviation4,374,537,256
Median5,730,000,000
Standard Deviation4,948,439,678
Sample Variance24487055.3T
Range13.5B
R-Value0.85
Mean Square Error7420391.9T
R-Squared0.72
Significance0.000035
Slope880,207,767
Total Sum of Squares367305828.8T

UnitedHealth Non Current Liabilities Other History

20258.7 B
202415.9 B
202314.5 B
202215.6 B
202115.1 B
202012.3 B
201910.1 B

About UnitedHealth Group Financial Statements

Investors use fundamental indicators, such as UnitedHealth Group's Non Current Liabilities Other, to determine how well the company is positioned to perform in the future. Although UnitedHealth Group's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Non Current Liabilities Other15.9 B8.7 B

Currently Active Assets on Macroaxis

When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.026
Dividend Share
8.18
Earnings Share
15.53
Revenue Per Share
434.612
Quarterly Revenue Growth
0.068
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.